Cancer Liver

Posts Tagged ‘tumor’

Liver tumors affect more than 300 children in the United States each year and management of these children requires coordinated comprehensive care from experts in many disciplines. To answer this problem, Texas Children’s Hospital and Baylor College of Medicine announced today the formation of a new Liver Tumor Center that brings together renowned specialists in all aspects of liver cancer who will utilize a multi-disciplinary approach to provide the most comprehensive and innovative care for children afflicted with these diseases. The Liver Tumor Center is the first to open in Texas and the Southwest, and is supported by the vast infrastructure provided by Texas Children’s Cancer Center (TCCC), the largest pediatric oncology and hematology center in the country and one of the finest places for children with cancer to receive care. To learn more about the Liver Tumor Center at TCCC, visit bit.ly

Product Description
Liver Cancer, the inaugural volume in the M.D. Anderson Solid Tumor Oncology series, provides the general surgeon, surgical oncologist, and medical oncologist with the most up-to-date and current standard of multimodality care for hepatobiliary cancer. Surgical approaches, chemotherapy, immunotherapy, gene therapy, and radiotherapy are all presented, giving the practitioner a much needed, comprehensive perspective on all aspects of patient care.

The MD Anderson Solid Tumor Oncology series features cutting-edge, in-depth information of vital interest to all practitioners in today’s captitated financial milieu. Providers must understand how their component of care interdigitates with the varied medical and surgical teams and apply multimodality approaches to their practice environments.

Liver Cancer

Product Description
Liver Cancer, the inaugural volume in the M.D. Anderson Solid Tumor Oncology series, provides the general surgeon, surgical oncologist, and medical oncologist with the most up-to-date and current standard of multimodality care for hepatobiliary cancer. Surgical approaches, chemotherapy, immunotherapy, gene therapy, and radiotherapy are all presented, giving the practitioner a much needed, comprehensive perspective on all aspects of patient care.

The MD Anderson Solid Tumor Oncology series features cutting-edge, in-depth information of vital interest to all practitioners in today’s captitated financial milieu. Providers must understand how their component of care interdigitates with the varied medical and surgical teams and apply multimodality approaches to their practice environments.

Liver Cancer

A liver cancer patient, treated by Dr. Rechelle Lanciano in Philadelphia Cyberknife, reports no evidence of cancer 2 months after the procedure. Cyberknife, the new robotic radiosurgery, can treat well-defined tumors in the whole body, including lung, liver, pancreas, kidney, prostate, brain and spine. www.PhillyCyberknife.com

• FlameEz-Colon is formulated to deliver optimal relief of immune and inflammatory responses, which cause tissue damage and unable to repair.
• FlameEz-Colon helps ease abdominal pain and diarrhea through effective removal of inflammatory toxins.
• FlameEz-Colon supplies natural antioxidants and enhances healing and defense.
• FlameEz-Colon helps control inflammation-tumor cross talk (“malignant flame”) which is the fuel that feeds tumor to grow and spread.
• FlameEz-Colon also works as a powerful total body cleanser to remove systemic inflammatory toxins, the primary contributors to aging and a wide range of chronic diseases.

Product Description
Inflammatory bowel disease (IBD) is caused by chronic inflammation in digestive tract which leads to severe abdominal pain and diarrhea. Crohn’s disease and ulcerative colitis are the most common forms of IBD. Chronic inflammation also plays a significant role in colon cancer. Inflammation promotes oxidative damage, DNA mutation, and cell transformation. Inflammatory mediators act as a tumor promoter, stimulate the proliferation of both untransformed and tumor cells. Tumor cells also amplify inflammatory responses by attracting more inflammatory cells to infiltrate the tumor. Such vicious cycle leads to tissue disruption and metastasis. The importance of inflammation in cancer progression has already led to clinical trials of anti-inflammatory cancer therapy. It is believed that anti-inflammatory drugs would prevent premalignant cells from turning fully cancerous or would impede an existing tumor from spreading to distant sites in the body. The results from clinical study show that people who regularly take Non-steroidal anti-inflammatory drugs (NSAIDs) have a lower risk of developing cancer than people who don’t take the drugs. But NSAIDs for cancer treatment is not ideal. These drugs have serious side effects including gastrointestinal bleeding and ulcer, as well as increased risks for heart attack and stroke. Alternatively, herbal remedies, used for centuries to treat various chronic inflammatory conditions, may supplement conventional cancer treatments. With less involvement of inflammatory cells, the premalignant cells would remain in check. FlameEz-Colon works as a powerful deep tissue cleanser to remove inflammatory toxins. If you are suffering from IBD or at risk for colon and stomach cancer, keeping inflammation in control is critically important! For more information, please visit www.FlameEz.com. *The information about this product has not been evaluated by the US FDA. This product is not intended to diagnose, treat, cure or prevent disease.

FlameEz-Colon, 60 Capsules/Bottle

The liver repairs by itself. It normally functions with only a little portion in working condition.

Primary cancer of the liver is a carcinoma which forms in the liver tissues. Secondary cancer of the liver is a cancer which scatters into the liver from other parts of the body.

Carcinoma or cancer starts in a cell. The cell is the building mass which makes up the tissues and the organs of the body are made up of tissues. Normal cells develop and divide in order to form fresh cells as needed by the human body. If normal cells become old or get busted, they expire, and then they replaced by new cells.

Occasionally, this procedure goes wrong. New cells are formed even if the body does not want them and damaged or old cells do not expire like they should. The building up of additional cells frequently forms mass of tissues known as nodule, growth or tumor.

Tumors in the liver may be benign or malignant. Benign tumor is not detrimental like malignant tumor. Most primary cancer of the liver starts in hepatocytes. This kind of malignancy is known as hepatocellular carcinoma or malignant hepatoma.

Cancer cells of the liver may scatter by flouting away from original growth or tumor. They scatter mainly by penetrating blood vessels, however, cancer cells of the liver may be found also in lymph nodes. Cancer cells can connect to some other tissues, also they develop to form fresh tumor that can spoil those tissues.

People suffering from liver cancer have many options for treatment, they are surgery (including transplant of liver), embolization, ablation, radiation therapy, targeted therapy and chemotherapy. The patient can have combined treatment.

The right treatment depends chiefly on the following: the number, location and size of growth in the liver, whether the tumor has scattered outside the liver or whether you are having cirrhosis and how excellent the liver is functioning. Other factors to put into consideration include the age, concerns regarding the treatment, general health and probable side effects.

At present, liver cancer may treated when it is discovered at early stage, meaning before it scattered and the person is healthy to undergo surgical procedures.

I am having a tumor removed from my kidney, possibly the whole kidney removed. What happens after? Will I be “normal” again? Will I feel sick, weak, ?????? Anyone know?

Someone just told me that her son has kidney cancer–and he’s only a year old. She didn’t give me any details, aside from the fact that the doctors found a tumor, but I was wondering how common it is for an infant to get kidney cancer?